Senior Director, US Commercial Finance Operations and GTN

This on site opportunity in Cambridge, MA offers a path to influence BioNTech US as it shifts toward a commercially focused finance organization. The Senior Director, US Commercial Finance Operations and Gross-to-Net leads financial oversight of sales processes and SOX compliance, collaborating with global stakeholders to build infrastructure, drive revenue recognition, pricing, and government pricing strategies. The role carries a competitive salary range of USD 198,900 – 318,300 per year and requires a finance degree with CPA preferred.

Benefits

• Medical, Dental and Vision Insurance
• Life, AD&D, Critical Illness Insurance
• Pre-tax HSA & FSA, DCRA Spending Accounts
• Employee Assistance & Concierge Program (EAP) available 24/7
• Parental and Childbirth Leave & Family Planning Assistance
• Sitterstream: Virtual Tutoring & Childcare Membership
• Paid Time Off: Vacation, Sick, Bereavement, Holidays (including Floating) & Year-End U.S. Shutdown
• 401(K) Plan with Company Match
• Tuition Reimbursement & Student Loan Assistance Programs
• Wellbeing Incentive Platforms & Incentives
• Professional Development Programs
• Commuting Allowance and subsidized parking
• Discounted Home, Auto & Pet Insurance

Responsibilities

• Maintain financial oversight for sales related processes including compliance to SOX and US federal anti-kickback statutes.
• Lead the development of US infrastructure and operational finance processes in partnership with global stakeholders, including Global Process Owners, Global Financial Reporting & Accounting, and Global Commercial Finance. Own L2C process execution in the US.
• Fully own Gross-to-Net (G2N) by preparing and reviewing journal entries, account reconciliations, and true-ups for sales deductions during month-end close.
• Support the establishment of the Gross to Net process for BioNTech USA with appropriate systems, collaborating with local and global stakeholders such as the global GPO L2C; help build internal Finance USA capabilities.
• Apply expert knowledge of discounts, rebates, Government Pricing, and the impact on ASP and net cost recovery for commercial and government payers.
• Lead US G2N reserve analysis and forecasting to mitigate risk and ensure accurate revenue recognition across commercial and government channels, including Medicare, Medicaid, and PBMs.
• Analyze variances between actuals and forecasts, delivering strategic insights on pricing, payer mix, and product launches to US leadership.
• Manage Government Pricing Reporting.
• Oversee outsourcing partnerships with external G2N providers, 3PLs, or 5 PLs, aligning with BNTX requirements and interfaces and evaluating internalization options with local and global stakeholders.
• Serve as primary contact for external and royalty audits, maintaining Reasonable Assumptions documentation and SOX-compliant SOPs.
• Advance the transformation of the US Finance organization from a research-centered to a commercial-centered focus, in collaboration with the US Finance Leadership Team.
• Build and lead an internal team over the coming years for select activities.

Requirements

• Finance degree, CPA preferred
• Curiosity to establish new processes from scratch in a fast-moving environment with global and local stakeholders
• 10+ years of experience in US pharma, preferably oncology, in Gross to Net, Accounts Receivable, Government pricing, and related general accounting activities
• Knowledge of distribution, group purchasing organizations, patient support programs, and 340B implications
• Public accounting experience, preferably in a SOX environment
• Experience with ERP transformation projects
• Willingness to assume personal accountability to establish new processes in a fast-moving environment with local and global stakeholders
• Demonstrated ability to navigate ambiguity
• Onsite presence required
• Role can be located in Cambridge, MA or Berkeley Heights, NJ